1. Metal Complexes of Isonicotinylhydrazide and Their Antitubercular Activity. Ali, M., M. Ahmed, S. Hafiz, M. Kamal, M. Mumtaz, M. Hanif, and K.M. Khan. Pakistan Journal of Pharmaceutical Sciences, 2017. 30(6(Supplementary)): p. 2399-2403. PMID[29188776].
[PubMed]. TB_11_2017.
2. Synthesis, Crystal Structure and Antimycobacterial Activities of 4-Indolyl-1,4-dihydropyridine Derivatives Possessing Various Ester Groups. Baydar, E., M.G. Gunduz, V.S. Krishna, R. Simsek, D. Sriram, S.O. Yildirim, R.J. Butcher, and C. Safak. Research on Chemical Intermediates, 2017. 43(12): p. 7471-7489. ISI[000414497800044].
[WOS]. TB_11_2017.
3. Anti-tuberculosis Activity and Structure-Activity Relationships of Oxygenated Tricyclic Carbazole Alkaloids and Synthetic Derivatives. Borger, C., C. Brutting, K.K. Julich-Gruner, R. Hesse, V.P. Kumar, S.K. Kutz, M. Ronnefahrt, C. Thomas, B. Wan, S.G. Franzblau, and H.J. Knolker. Bioorganic & Medicinal Chemistry, 2017. 25(22): p. 6167-6174. PMID[28094223].
[PubMed]. TB_11_2017.
4. Natural Isoflavone Biochanin A as a Template for the Design of New and Potent 3-Phenylquinolone Efflux Inhibitors against Mycobacterium avium. Cannalire, R., D. Machado, T. Felicetti, S.S. Costa, S. Massari, G. Manfroni, M.L. Barreca, O. Tabarrini, I. Couto, M. Viveiros, S. Sabatini, and V. Cecchetti. European Journal of Medicinal Chemistry, 2017. 140: p. 321-330. PMID[28964936].
[PubMed]. TB_11_2017.
5. Bis-spirochromanones as Potent Inhibitors of Mycobacterium tuberculosis: Synthesis and Biological Evaluation. Dongamanti, A., V.K. Aamate, M.G. Devulapally, S. Gundu, S. Balabadra, V. Manga, P. Yogeeswari, D. Sriram, and S. Balasubramanian. Molecular Diversity, 2017. 21(4): p. 999-1010. PMID[28840414].
[PubMed]. TB_11_2017.
6. Synthesis and in Vitro Antimycobacterial Activity of Novel N-Arylpiperazines Containing an Ethane-1,2-diyl Connecting Chain. Gonec, T., I. Malik, J. Csollei, J. Jampilek, J. Stolarikova, I. Solovic, P. Mikus, S. Keltosova, P. Kollar, J. O'Mahony, and A. Coffey. Molecules, 2017. 22(12): E2100. PMID[29189762].
[PubMed]. TB_11_2017.
7. Dual Mechanism of Action of 5-Nitro-1,10-phenanthroline against Mycobacterium tuberculosis. Kidwai, S., C.Y. Park, S. Mawatwal, P. Tiwari, M.G. Jung, T.P. Gosain, P. Kumar, D. Alland, S. Kumar, A. Bajaj, Y.K. Hwang, C.S. Song, R. Dhiman, I.Y. Lee, and R. Singh. Antimicrobial Agents and Chemotherapy, 2017. 61(11): e00969-17. PMID[28893784]. PMCID[PMC5655107].
[PubMed]. TB_11_2017.
8. In Vitro Effect of DFC-2 on Mycolic acid Biosynthesis in Mycobacterium tuberculosis. Kim, S., H. Seo, H.A. Mahmud, M.I. Islam, Y.S. Kim, J. Lyu, K.W. Nam, B.E. Lee, K.I. Lee, and H.Y. Song. Journal of Microbiology and Biotechnology, 2017. 27(11): p. 1932-1941. PMID[28870005].
[PubMed]. TB_11_2017.
9. Synthesis and Antimycobacterial Activity of N-Isonicotinoyl-N'-alkylideneferrocenecarbohydrazides. Kulikov, V.N., R.S. Nikulin, A.N. Rodionov, E.S. Babusenko, V.N. Babin, L.V. Kovalenko, and Y.A. Belousov. Russian Chemical Bulletin, 2017. 66(6): p. 1122-1125. ISI[000413459100031].
[WOS]. TB_11_2017.
10. Biosynthesis of Methyl-proline Containing Griselimycins, Natural Products with Anti-tuberculosis Activity. Lukat, P., Y. Katsuyama, S. Wenzel, T. Binz, C. Konig, W. Blankenfeldt, M. Bronstrup, and R. Muller. Chemical Science, 2017. 8(11): p. 7521-7527. PMID[29163906]. PMCID[PMC5676206].
[PubMed]. TB_11_2017.
11. The Antitubercular Activity of Various Nitro(triazole/imidazole)-based Compounds. Papadopoulou, M.V., W.D. Bloomer, and H.S. Rosenzweig. Bioorganic & Medicinal Chemistry, 2017. 25(21): p. 6039-6048. PMID[28993106].
[PubMed]. TB_11_2017.
12. Synthesis of Substrate Analogues as Potential Inhibitors for Mycobacterium tuberculosis Enzyme MshC. Patel, K., F. Song, and P.R. Andreana. Carbohydrate Research, 2017. 453-454: p. 10-18. PMID[29107814].
[PubMed]. TB_11_2017.
13. The Synthesis, Biological Evaluation and Structure-Activity Relationship of 2-Phenylaminomethylene-cyclohexane-1,3-diones as Specific Antituberculosis Agents. Rather, M.A., A.M. Lone, B. Teli, Z.S. Bhat, P. Singh, M. Maqbool, B.A. Shairgojray, M.J. Dar, S. Amin, S.K. Yousuf, B.A. Bhat, and Z. Ahmad. MedChemComm, 2017. 8(11): p. 2133-2141. ISI[000415333600013].
[WOS]. TB_11_2017.
14. Evaluation of Antituberculosis Activity and DFT Study on Dipyrromethane-derived Hydrazone Derivatives. Rawat, P., R.N. Singh, P. Niranjan, A. Ranjan, and N.R.F. Holguin. Journal of Molecular Structure, 2017. 1149: p. 539-548. ISI[000413387300056].
[WOS]. TB_11_2017.
15. Development of Water-soluble 3,5-Dinitrophenyl Tetrazole and Oxadiazole Antitubercular Agents. Roh, J., G. Karabanovich, H. Vlckova, A. Carazo, J. Nemecek, P. Sychra, L. Valaskova, O. Pavlis, J. Stolarikova, V. Klimesova, K. Vavrova, P. Pavek, and A. Hrabalek. Bioorganic & Medicinal Chemistry, 2017. 25(20): p. 5468-5476. PMIDI[28835350].
[PubMed]. TB_11_2017.
16. New 1-Hydroxy-2-thiopyridine Derivatives Active against Both Replicating and Dormant Mycobacterium tuberculosis. Salina, E.G., O. Ryabova, A. Vocat, B. Nikonenko, S.T. Cole, and V. Makarov. Journal of Infection and Chemotherapy, 2017. 23(11): p. 794-797. PMID[28527650].
[PubMed]. TB_11_2017.
17. Antimicrobial Efficacy of Synthetic Pyranochromenones and (Coumarinyloxy)acetamides. Singh, A.K., S. Prasad, B. Kumar, S. Kumar, A. Anand, S.S. Kamble, S.K. Sharma, and H.K. Gautam. Indian Journal of Microbiology, 2017. 57(4): p. 499-502. PMID[29151652]. PMCID[PMC5671431].
[PubMed]. TB_11_2017.
18. Biological Evaluation of Diphenyleneiodonium chloride (DPIC) as a Potential Drug Candidate for Treatment of Non-tuberculous Mycobacterial Infections. Singh, A.K., R. Thakare, P. Karaulia, S. Das, I. Soni, M. Pandey, A.K. Pandey, S. Chopra, and A. Dasgupta. Journal of Antimicrobial Chemotherapy, 2017. 72(11): p. 3117-3121. PMID[28961864].
[PubMed]. TB_11_2017.
19. Biological Evaluation of Novel Curcumin-pyrazole-mannich Derivative Active against Drug-resistant Mycobacterium tuberculosis. Singh, A.K., P. Yadav, P. Karaulia, V.K. Singh, P. Gupta, S.K. Puttrevu, S. Chauhan, R.S. Bhatta, N. Tadigoppula, U.D. Gupta, S. Chopra, and A. Dasgupta. Future Microbiology, 2017. 12: p. 1349-1362. PMID[29035081].
[PubMed]. TB_11_2017.
20. Novel 6-Phenylnicotinohydrazide Derivatives: Design, Synthesis and Biological Evaluation as a Novel Class of Antitubercular and Antimicrobial Agents. Soliman, D.H., W.M. Eldehna, H.A. Ghabbour, M.M. Kabil, M.M. Abdel-Aziz, and H.A.K. Abdel-Azizh. Biological & Pharmaceutical Bulletin, 2017. 40(11): p. 1883-1893. PMID[29093335].
[PubMed]. TB_11_2017.
21. Novel 2-Methyl-6-arylpyridines Carrying Active Pharmacophore 4,5-Dihydro 2-Pyrazolines: Synthesis, Antidepressant, and Anti-tuberculosis Evaluation. Sowmya, P.V., B. Poojary, B.C. Revanasiddappa, M. Vijayakumar, P. Nikil, and V. Kumar. Research on Chemical Intermediates, 2017. 43(12): p. 7399-7422. ISI[000414497800040].
[WOS]. TB_11_2017.
22. Identification of a Novel Class of Small Compounds with Anti-tuberculosis Activity by in Silico Structure-based Drug Screening. Taira, J., K. Morita, S. Kawashima, T. Umei, H. Baba, T. Maruoka, H. Komatsu, H. Sakamoto, J.C. Sacchettini, and S. Aoki. The Journal of Antibiotics, 2017. 70(11): p. 1057-1064. PMID[28951604].
[PubMed]. TB_11_2017.
23. New Amide and Dioxopiperazine Derivatives from Leaves of Breynia nivosa. Umeokoli, B.O., F.A. Onyegbule, F.B.C. Okoye, H. Wang, R. Kalscheuer, W.E.G. Muller, R. Hartmann, Z. Liu, and P. Proksch. Fitoterapia, 2017. 122: p. 16-19. PMID[28830789].
[PubMed]. TB_11_2017.
Patent Citations
24. Preparation of Cephalosporin-type Compounds for the Treatment of Bacterial and Fungal Infections. Gold, B.S., J. Aube, C.F. Nathan, Q. Nguyen, F.J. Schoenen, and R.A. Smith. Patent. 2017. 2017-US30177 2017190043: 101pp.
[Patent]. TB_11_2017.
25. Synthesis of Azasteroids for Treatment of Tuberculosis. Sampson, N., X. Yang, and T. Yuan. Patent. 2017. 2017-US30166 2017190034: 115pp.
[Patent]. TB_11_2017.
26. Preparation of Anti-infective 2-Aminothiophenes. Sucheck, S., S. Thanna, and R. Slayden. Patent. 2017. 2017-US28782 2017184947: 131pp.
[Patent]. TB_11_2017.